Olanzapine Impurity 17(CAS: 639460-79-0)

Olanzapine Impurity 17 (CAS: 639460-79-0) is a by-product of the synthesis of olanzapine, an atypical antipsychotic medication used to treat schizophrenia and bipolar disorder. It is characterized by its chemical structure and properties similar to olanzapine but with variations that affect its pharmacological activity.

Olanzapine Impurity 17 (CAS: 639460-79-0) is primarily used in the pharmaceutical industry as a reference standard for quality control and impurity analysis during the manufacture of olanzapine. It plays a critical role in ensuring the purity and efficacy of olanzapine medications.

Olanzapine Impurity 17 (CAS: 639460-79-0) is generally safe when handled under proper laboratory conditions. However, it is important to follow all safety guidelines, including wearing appropriate personal protective equipment (PPE) and ensuring proper ventilation. Exposure to this impurity can be harmful if ingested or inhaled, and it should be disposed of according to hazardous waste regulations.

Olanzapine Impurity 17 (CAS: 639460-79-0) should be stored in a cool, dry place, away from direct sunlight and high temperatures. It should be kept in a tightly sealed container to prevent contamination and degradation. Optimal storage conditions include a temperature range of 15-25°C (59-77°F) and a relative humidity below 60%. Proper containerization is essential to maintain the stability and safety of the impurity during storage and transportation.